AP1358A - 1-Aryl-2-Hydroxy-3-Isoquinoline Carboxamide HIV Protease Inhibitors, Their Preparation and Use. - Google Patents

1-Aryl-2-Hydroxy-3-Isoquinoline Carboxamide HIV Protease Inhibitors, Their Preparation and Use. Download PDF

Info

Publication number
AP1358A
AP1358A APAP/P/1999/001648A AP9901648A AP1358A AP 1358 A AP1358 A AP 1358A AP 9901648 A AP9901648 A AP 9901648A AP 1358 A AP1358 A AP 1358A
Authority
AP
ARIPO
Prior art keywords
alkyl
compound
group
purity
hiv
Prior art date
Application number
APAP/P/1999/001648A
Other languages
English (en)
Other versions
AP9901648A0 (en
Inventor
Kim F Albizati
Siegfried Reich
Michael D Varney
Kanyin E Zhang
Takuo Kobayashi
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Publication of AP9901648A0 publication Critical patent/AP9901648A0/xx
Application granted granted Critical
Publication of AP1358A publication Critical patent/AP1358A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
APAP/P/1999/001648A 1997-03-13 1998-03-12 1-Aryl-2-Hydroxy-3-Isoquinoline Carboxamide HIV Protease Inhibitors, Their Preparation and Use. AP1358A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13
PCT/US1998/004735 WO1998040357A2 (en) 1997-03-13 1998-03-12 Hiv protease inhibitors

Publications (2)

Publication Number Publication Date
AP9901648A0 AP9901648A0 (en) 1999-09-30
AP1358A true AP1358A (en) 2004-12-03

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1999/001648A AP1358A (en) 1997-03-13 1998-03-12 1-Aryl-2-Hydroxy-3-Isoquinoline Carboxamide HIV Protease Inhibitors, Their Preparation and Use.

Country Status (35)

Country Link
EP (1) EP0970055A2 (es)
JP (1) JP2001516350A (es)
KR (1) KR100511089B1 (es)
CN (1) CN1179948C (es)
AP (1) AP1358A (es)
AR (1) AR012556A1 (es)
AU (1) AU743078B2 (es)
BG (1) BG63540B1 (es)
BR (1) BR9808867A (es)
CA (1) CA2284163A1 (es)
CO (1) CO4940496A1 (es)
CZ (1) CZ296647B6 (es)
EA (1) EA002378B1 (es)
EE (1) EE04114B1 (es)
GE (1) GEP20022764B (es)
HR (1) HRP980112A2 (es)
HU (1) HUP0001380A3 (es)
IL (2) IL131870A0 (es)
IS (1) IS5176A (es)
MX (1) MXPA99008395A (es)
MY (1) MY117535A (es)
NO (1) NO315555B1 (es)
NZ (1) NZ337706A (es)
OA (1) OA11196A (es)
PA (1) PA8448801A1 (es)
PE (1) PE58799A1 (es)
PL (1) PL192786B1 (es)
SA (1) SA98181116B1 (es)
SK (1) SK283636B6 (es)
SV (1) SV1998000038A (es)
TR (1) TR199902508T2 (es)
TW (1) TW200517112A (es)
UA (1) UA57772C2 (es)
WO (1) WO1998040357A2 (es)
ZA (1) ZA982047B (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009843A1 (en) * 1993-10-07 1995-04-13 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009843A1 (en) * 1993-10-07 1995-04-13 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. of Pharm. Sci. V. 84. No. 9, pp 1090-93 (1995) *

Also Published As

Publication number Publication date
EP0970055A2 (en) 2000-01-12
BR9808867A (pt) 2000-07-11
NO994415D0 (no) 1999-09-10
EA199900823A1 (ru) 2000-04-24
PE58799A1 (es) 1999-07-12
NZ337706A (en) 2001-04-27
WO1998040357A3 (en) 1998-11-26
HRP980112A2 (en) 1998-12-31
PA8448801A1 (es) 2000-05-24
EE9900416A (et) 2000-04-17
SK283636B6 (sk) 2003-11-04
AR012556A1 (es) 2000-11-08
TW200517112A (en) 2005-06-01
SV1998000038A (es) 1999-02-15
AP9901648A0 (en) 1999-09-30
PL335672A1 (en) 2000-05-08
WO1998040357A2 (en) 1998-09-17
IL131870A (en) 2006-04-10
CZ296647B6 (cs) 2006-05-17
CA2284163A1 (en) 1998-09-17
AU743078B2 (en) 2002-01-17
BG63540B1 (bg) 2002-04-30
KR100511089B1 (ko) 2005-08-31
SK122299A3 (en) 2000-05-16
CN1253548A (zh) 2000-05-17
CN1179948C (zh) 2004-12-15
CZ319199A3 (cs) 2000-06-14
ZA982047B (en) 1998-09-28
MXPA99008395A (es) 2003-08-12
SA98181116B1 (ar) 2006-10-04
IS5176A (is) 1999-09-10
EA002378B1 (ru) 2002-04-25
NO994415L (no) 1999-11-10
IL131870A0 (en) 2001-03-19
UA57772C2 (uk) 2003-07-15
NO315555B1 (no) 2003-09-22
KR20000076236A (ko) 2000-12-26
EE04114B1 (et) 2003-08-15
HUP0001380A2 (hu) 2000-09-28
BG103727A (en) 2000-04-28
GEP20022764B (en) 2002-08-26
TR199902508T2 (xx) 2000-02-21
JP2001516350A (ja) 2001-09-25
AU6457598A (en) 1998-09-29
CO4940496A1 (es) 2000-07-24
OA11196A (en) 2003-05-21
MY117535A (en) 2004-07-31
HUP0001380A3 (en) 2001-12-28
PL192786B1 (pl) 2006-12-29

Similar Documents

Publication Publication Date Title
KR100296462B1 (ko) 레트로바이러스프로테아제억제제로서유용한술포닐알칸오일아미노히드록시에틸아미노술폰아미드
ES2568629T3 (es) Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
US20080103311A1 (en) Retroviral protease inhibitors
JPH06271534A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
US5527829A (en) HIV protease inhibitors
JPH08500824A (ja) レトロウイルスプロテアーゼ阻害剤として有用なn−(アルカノイルアミノ−2−ヒドロキシプロピル)スルホンアミド
JPH07179417A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
ES2201524T3 (es) Derivados de epoxisuccinamida.
JPH06234728A (ja) Aidsの処置のために有用なhiv−プロテアーゼ阻害剤
JPH09509657A (ja) 中間体および製造のための方法
AP1358A (en) 1-Aryl-2-Hydroxy-3-Isoquinoline Carboxamide HIV Protease Inhibitors, Their Preparation and Use.
US6001851A (en) HIV protease inhibitors
EP3946301A1 (en) Remodilins for airway remodeling and organ fibrosis
US20040267022A1 (en) Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
PT101026A (pt) 6-fenil-5-amino-4-hidroxi-hexanoil-valil-guanidinas substituidas como inibidores da protease de hiv